Latest

Weight-loss drugmaker Novo Nordisk slims sales forecast
Weight-loss drugmaker Novo Nordisk slims sales forecast
Economy
by  AFP

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its annual sales forecast on Wednesday, citing a decline in its US market share. Novo Nordisk's shares tumbled last month after Eli Lilly announced a successful clinical trial of diabetes and obesity treatment orforglipron.